Please login to the form below

US drug prices

This page shows the latest US drug prices news and features for those working in and with pharma, biotech and healthcare.

US politicians round on generics firms for blocking drug pricing probe

Renews focus on increases in generic drug prices. US politicians are going after Heritage Pharmaceuticals, Mylan and Teva Pharmaceutical Industries for allegedly stonewalling an earlier effort to gather drug pricing information. ... That’s when Elijah

Latest news

White House unveils plans to reimport medicines from Canada

The plans are an escalation in the president’s on-off assault on drug prices, which he and his Republican party, and the opposition Democrat party, are focusing on as a ... tackle high drug prices.
PhRMA opposed to Senate drug price control plans

But has bipartisan support and Trump backing. Long-awaited Senate Finance Committee proposals to tackle high drug prices through Medicare and Medicaid have been slammed by the trade organisation representing pharma ... Republican Senator Chuck Grassley
Another setback on pricing as Trump drops rebate plans

Follows pharma's blocking of advertising changes. The Trump Administration has abandoned yet another pillar of its plan to reduce medicine prices in the US, this time its proposal to eliminate ... It’s the second defeat for the President this week,
Trump presses on with reference pricing plan for medicines

Setting US prices against those overseas is just the latest in a series of new proposals in Trump’s war on drug prices, coming after plans to do away with the ... US. Health secretary Alex Azar had previously tweeted that in 2018 drug companies
Sanofi joins Lilly in insulin price cut, but lawmakers have lost patience

Insulin price nearly tripled between 2002 and 2013. Drug makers and pharmacy benefit managers continued to point fingers over the blame for escalating prices of insulin in the US at a ... why list prices are so high, given that the average price of

More from news
Approximately 12 fully matching, plus 21 partially matching documents found.

Latest Intelligence

The Orkambi blame game

The three-hour evidence session also bore some resemblance to the recent interrogation of seven big pharma CEOs by a US Senate committee enquiry into US drug prices, albeit with just ... were ‘freeloading’ while high US prices provide the incentive
Deal Watch October 2018

US drug prices. In other news from the US, there are now expectations of a legislative stalemate following the mid‐term elections in early November. ... It is worth remembering that there are still a few areas where both political parties are prepared
The handover: Pfizer reshapes itself for a new era

Trump had tweeted days before that Pfizer “should be ashamed that they have raised drug prices for no reason”, claiming they were “taking advantage of the poor and others unable to ... The Trump administration has also just floated the idea of
Deal Watch January 2017

bear on US drug prices and the possible revocation of Obamacare in part, if not in full. In addition, early press coverage suggests that there may be an introduction of a ... 230. Cymabay. Kowa. Exclusive licence in the US. Arhalofenate for gout p3
Tracking comms trends: Europe in the global vanguard on value

But this is changing. President Obama, plus candidates Donald Trump and Hillary Clinton, have all proposed that Medicare should negotiate drug prices. ... More locally, US HMOs and insurance funds are using levels of HTA and deploying cost containment

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Account Director – UK Office: Excellent salary and benefits

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Account Manager – Healthcare advertising: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...